Fluorescence spectroscopy as an efficient tool for staging the degree of liver fibrosis: an in vivo comparison with MRI

The study utilizes autofluorescence spectroscopy (AFS) along with multivariate spectral analysis for differentiating various stages of hepatic fibrosis. AFS has recently emerged as an efficient tool for evaluating the variations in different endogenous flurophores. In this study, the potential of AFS for differentiating the stages of liver fibrosis is assessed and compared with the results of enzyme evaluation, histopathology and the most advanced diagnostic tool, MRI. Using a fiber optic probe, the emission profile of the flurophores such as flavin adenine dinucleotide (FAD), lipofuscin-like lipopigments (lipopigments), porphyrins and the variation in the total hemoglobin concentration are evaluated in vivo on liver fibrosis induced animal models adopting a minimally invasive technique. Significant difference (p < 0.05) in the level of these biomarkers was observed between different stages of liver fibrosis. Normal hepatic tissue could be distinguished from mild and moderate hepatic fibrosis with a sensitivity of 95 to 100% and specificity of 90 to 100% using multivariate spectral analysis. The results are favourable to consider this technique as a potential tool for diagnosing liver fibrosis at an early stage, which is monumental as it otherwise can lead to cirrhosis and liver failure.

[1]  G. Bottiroli,et al.  Fatty liver oxidative events monitored by autofluorescence optical diagnosis: Comparison between subnormothermic machine perfusion and conventional cold storage preservation , 2017, Hepatology research : the official journal of the Japan Society of Hepatology.

[2]  Arun Gupta,et al.  Fluorescence spectroscopy to discriminate neoplastic human brain lesions: a study using the spectral intensity ratio and multivariate linear discriminant analysis , 2014 .

[3]  M Zanello,et al.  Spectral and lifetime domain measurements of rat brain tumors. , 2015, Biomedical optics express.

[4]  S. Hewitt,et al.  Infrared spectroscopic imaging for histopathologic recognition , 2005, Nature Biotechnology.

[5]  N. Krishnakumar,et al.  Monitoring the metabolic response to nanoencapsulated silibinin treatment in DMBA-induced oral carcinogenesis using endogenous fluorescence , 2014 .

[6]  J Popp,et al.  Raman Spectroscopic Detection of Anthrax Endospores in Powder Samples** , 2012, Angewandte Chemie.

[7]  G. van Kaick,et al.  Hepatic phospholipids in alcoholic liver disease assessed by proton-decoupled 31P magnetic resonance spectroscopy. , 2005, Journal of hepatology.

[8]  E. Joshua,et al.  A rapid and noninvasive method to detect dried saliva stains from human skin using fluorescent spectroscopy , 2011, Journal of oral and maxillofacial pathology : JOMFP.

[9]  C. Murali Krishna,et al.  Serum Based Diagnosis of Asthma Using Raman Spectroscopy: An Early Phase Pilot Study , 2013, PloS one.

[10]  N. Krishnakumar,et al.  Endogenous porphyrin fluorescence as a biomarker for monitoring the anti-angiogenic effect in antitumor response to hesperetin loaded nanoparticles in experimental oral carcinogenesis , 2014 .

[11]  Göran Hansson,et al.  Increased Porphyrins in Primary Liver Cancer Mainly Reflect a Parallel Liver Disease , 2009, Gastroenterology research and practice.

[12]  Vishal K. Varma,et al.  Infrared spectroscopic imaging: Label-free biochemical analysis of stroma and tissue fibrosis. , 2017, The international journal of biochemistry & cell biology.

[13]  F. X. Bosch,et al.  Epidemiology of Primary Liver Cancer , 1999, Seminars in liver disease.

[14]  L. Deckelbaum.  Fluorescence spectroscopy in cardiovascular disease Fundamental concepts and clinical applications. , 1991, Trends in cardiovascular medicine.

[15]  Ariya Saraswathy,et al.  Optimum wavelength for the differentiation of brain tumor tissue using autofluorescence spectroscopy. , 2009, Photomedicine and laser surgery.

[16]  B. Wood,et al.  Monitoring the biochemical alterations in hypertension affected salivary gland tissues using Fourier transform infrared hyperspectral imaging. , 2017, The Analyst.

[17]  Pierre-Yves Boëlle,et al.  Diffusion‐weighted magnetic resonance imaging for the assessment of fibrosis in chronic hepatitis C , 2007, Hepatology.

[18]  Angel Orte,et al.  Fluorescent nanoparticles for intracellular sensing: a review. , 2012, Analytica chimica acta.

[19]  Zeng-meng Wang,et al.  Assessment of liver fibrosis by Fibroscan as compared to liver biopsy in biliary atresia. , 2015, World journal of gastroenterology.

[20]  R. Jayasree,et al.  Synthesis and characterization of dextran stabilized superparamagnetic iron oxide nanoparticles for in vivo MR imaging of liver fibrosis. , 2014, Carbohydrate polymers.

[21]  A. Kakita,et al.  Relationship between the recurrence of hepatocellular carcinoma (HCC) and serum alanine aminotransferase levels in hepatectomized patients with hepatitis C virus‐associated cirrhosis and HCC , 1997, Cancer.

[22]  Arun Kumar Gupta,et al.  Noninvasive assessment of the risk of tobacco abuse in oral mucosa using fluorescence spectroscopy: a clinical approach , 2014, Journal of biomedical optics.

[23]  Shaiju S. Nazeer,et al.  Diagnosis of Breast Cancer Based on FT‐IR Spectroscopy , 2008 .

[24]  R. Jayasree,et al.  Citrate coated iron oxide nanoparticles with enhanced relaxivity for in vivo magnetic resonance imaging of liver fibrosis. , 2014, Colloids and surfaces. B, Biointerfaces.

[25]  V. de Lédinghen,et al.  Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study , 2005, Gut.

[26]  R. Testa,et al.  Validity and clinical utility of the aspartate aminotransferase-alanine aminotransferase ratio in assessing disease severity and prognosis in patients with hepatitis C virus-related chronic liver disease. , 2003, Archives of internal medicine.

[27]  A. Floreani,et al.  Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis. , 1995, Journal of hepatology.

[28]  C. Sharma,et al.  Fluorescent gold clusters as nanosensors for copper ions in live cells. , 2011, The Analyst.

[29]  S. Hubscher,et al.  Histological assessment of non-alcoholic fatty liver disease. , 2006 .

[30]  Thomas Albrecht,et al.  Non-invasive diagnosis of hepatic cirrhosis by transit-time analysis of an ultrasound contrast agent , 1999, The Lancet.

[31]  R. Martinus,et al.  Ovine ceroid-lipofuscinosis. I: Lipopigment composition is indicative of a lysosomal proteinosis. , 1988, American journal of medical genetics. Supplement.

[32]  Narayanan Subhash,et al.  Clinical grading of oral mucosa by curve‐fitting of corrected autofluorescence using diffuse reflectance spectra , 2009, Head & neck.

[33]  H. Adami,et al.  Alcoholism and liver cirrhosis in the etiology of primary liver cancer , 1992, International journal of cancer.

[34]  Jayaraj L. Jayanthi,et al.  Comparative evaluation of the diagnostic performance of autofluorescence and diffuse reflectance in oral cancer detection: a clinical study , 2011, Journal of biophotonics.

[35]  P. Jeemon,et al.  Diffuse reflectance spectroscopy: diagnostic accuracy of a non-invasive screening technique for early detection of malignant changes in the oral cavity , 2011, BMJ Open.

[36]  G. Escobedo,et al.  In vivo assessment of liver fibrosis using diffuse reflectance and fluorescence spectroscopy: a proof of concept. , 2012, Photodiagnosis and photodynamic therapy.

[37]  F. Schick,et al.  Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance. , 2009, Journal of hepatology.

[38]  Tuan Vo-Dinh,et al.  Spectral filtering modulation method for estimation of hemoglobin concentration and oxygenation based on a single fluorescence emission spectrum in tissue phantoms. , 2009, Medical physics.

[39]  R. Jayasree,et al.  Autofluorescence spectroscopy for the in vivo evaluation of oral submucous fibrosis. , 2009, Photomedicine and laser surgery.

[40]  J. Iredale,et al.  Modeling liver fibrosis in rodents. , 2005, Methods in molecular medicine.

[41]  S. Nazeer Shaiju,et al.  Habits with killer instincts: in vivo analysis on the severity of oral mucosal alterations using autofluorescence spectroscopy. , 2011, Journal of biomedical optics.

[42]  O. Yokosuka,et al.  Pathophysiology of Portal Hypertension and Esophageal Varices , 2012, International journal of hepatology.

[43]  VenugopalC.,et al.  Autofluorescence spectroscopy augmented by multivariate analysis as a potential noninvasive tool for early diagnosis of oral cavity disorders. , 2013 .

[44]  Arun Kumar Gupta,et al.  Fluorescence spectroscopy as a highly potential single-entity tool to identify chromophores and fluorophores: study on neoplastic human brain lesions , 2013, Journal of biomedical optics.

[45]  Richard L Ehman,et al.  Magnetic resonance imaging of hepatic fibrosis: Emerging clinical applications , 2007, Hepatology.

[46]  W. Zwiebel,et al.  Sonographic diagnosis of diffuse liver disease. , 1995, Seminars in ultrasound, CT, and MR.

[47]  J. Roodenburg,et al.  Autofluorescence and diffuse reflectance spectroscopy for oral oncology , 2005, Lasers in surgery and medicine.

[48]  N. Afdhal.  Fibroscan (transient elastography) for the measurement of liver fibrosis. , 2012, Gastroenterology & hepatology.

[49]  Chih-Ching Huang,et al.  Fluorescent gold and silver nanoclusters for the analysis of biopolymers and cell imaging , 2012 .

[50]  K. Satyamoorthy,et al.  Spectroscopic and histological evaluation of wound healing progression following Low Level Laser Therapy (LLLT) , 2012, Journal of biophotonics.

[51]  Fabrice Carrat,et al.  Liver biopsy: the best, not the gold standard. , 2009, Journal of hepatology.

[52]  Tuan Vo-Dinh,et al.  Compact point-detection fluorescence spectroscopy system for quantifying intrinsic fluorescence redox ratio in brain cancer diagnostics. , 2011, Journal of biomedical optics.

[53]  R. Jayasree,et al.  Optical diagnosis of the progression and reversal of CCl4-induced liver injury in rodent model using minimally invasive autofluorescence spectroscopy. , 2015, The Analyst.

[54]  S REITMAN,et al.  A colorimetric method for the determination of serum glutamic oxalacetic and glutamic pyruvic transaminases. , 1957, American journal of clinical pathology.